Magnesium and calcium reveal different chelating effects in a steroid compound: A model study of prednisolone using NMR spectroscopy.

Steroids

Institute of Chemistry, Academia Sinica, Nankang, Taipei 11529, Taiwan, ROC; Department of Applied Chemistry, National Chia-Yi University, Chia-Yi 60004, Taiwan, ROC. Electronic address:

Published: October 2019

In this work, we used high resolution NMR spectroscopy to investigate metal cation chelation by the steroidal drug 1,4-pregnadiene-11β,17α,21-triol-3,20-dione (Prednisolone; abbreviated as Prd). Prd/MgCl and Prd/CaCl mixtures were prepared at eight different molar ratios. Using two-dimensional H/C heteronuclear correlation spectroscopy, we were able to resolve most of the H signals, except those at 1.4-1.55 ppm, where signals for H15β, H16α and Me-19 are superimposed. The chelation sites were determined by the cation concentration-dependent C signals. Both ring A and ring D of Prd were found to be involved in Mg chelation, whereas only ring A was involved in Ca chelation. The dihedral angles deduced from the J coupling constants indicated that ring D of Prd might undergo rather small, but different, distortions in the presence of Mg and Ca. Additionally, using the continuous variation method, we deduced that the stoichiometric ratios of the Prd/Mg and Prd/Ca complexes were 1:1 and 2:1, respectively. All of the evidence led us to conclude that the Prd/Mg and Prd/Ca complexes are mediated by different chelating mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.steroids.2019.108429DOI Listing

Publication Analysis

Top Keywords

nmr spectroscopy
8
ring prd
8
involved chelation
8
prd/mg prd/ca
8
prd/ca complexes
8
magnesium calcium
4
calcium reveal
4
reveal chelating
4
chelating effects
4
effects steroid
4

Similar Publications

In this study, the structure of a new boron compound obtained using 3-methoxy catechol and 4-methoxy phenyl boronic acid was characterized by H, C NMR, LC-MS-IT-TOF, UV-Vis and FTIR spectroscopy. The antioxidant activities of the newly synthesized compound were evaluated by DPPH free radical scavenging, ABTS quation radical scavenging and CUPRAC copper reducing capacity methods. Anticholinesterase activities were determined by acetylcholinesterase and butyrylcholinesterase enzyme inhibitor assays.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Background: The role of circulating metabolome in cognitive impairment is limited and inconclusive. We aimed to identify plasma metabolites associated with cognitive impairment and evaluate the added predictive capacity of metabolite biomarkers on incident cognitive impairment beyond traditional risk factors.

Method: In the community-based Rugao Longevity and Ageing Study (RuLAS), plasma metabolome was profiled by nuclear magnetic resonance (NMR) spectroscopy.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Background: N-acetyl-aspartate (NAA) and myo-inositol (mI) are neurometabolites reflecting neuronal viability and astrocyte activity, respectively. These can be quantified in vivo using proton magnetic resonance spectroscopy (1H-MRS). Previous studies have suggested that these metabolites could serve as biomarkers for Alzheimer's disease dementia (AD).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Aging Research Center, Karolinska Institutet, Stockholm, Sweden.

Background: Growing evidence indicates that people with neurodegenerative diseases have altered metabolic status, but the association between metabolic age (MetAge), as assessed by circulating plasma metabolomics, and dementia remains unclear. We aimed to investigate the association between MetAge and risk of dementia and to explore whether genetic background plays a role in these associations.

Method: From the UK Biobank, 153,436 dementia-free adults aged ≥55 (mean age 62.

View Article and Find Full Text PDF

Background: Alzheimer's disease is a devastating neurodegenerative disorder with a complex pathogenesis. One main pathological feature utilised in diagnosis is neurodegeneration or neuronal injury, which is reflected in reductions in cerebral glucose metabolism measured by [18F]Fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET). Here we evaluated the involvement of glial reactivity measured with magnetic resonance spectroscopy (MRS) and cerebral blood flow measured with arterial spin labelling (ASL) on [18F]FDG PET as a measure of cerebral glucose metabolism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!